Myanmar Dengue Outbreak Associated with Displacement of Serotypes 2, 3, and 4 by Dengue 1

Emerging Infectious Diseases

Volumn 10, Issue 4, 2004, Pages 593-597

  Thu, Hlaing Myat ^a,b   Lowry, Kym ^a   Myint, Thein Thein ^c   Shwe, Than Nu ^c   Han, Aye Maung ^c   Khin, Kyu Kyu ^d   Thant, Kyaw Zin ^b   Thein, Soe ^b   Aaskov, John ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b Department of Medical Research ^*  (Myanmar)

^c Yangon Children's Hospital   (Myanmar)

^d Mawlamyaing General Hospital   (Myanmar)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS RNA;

AEDES ALBOPICTUS; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; EPIDEMIC; HUMAN; IMMUNOFLUORESCENCE; MYANMAR; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; SEROTYPE; SERUM; VIRUS ISOLATION; WEATHER;

EID: 1842588772     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1004.030216     Document Type: Article

References (25)

1. Dengue haemorrhagic fever. Diagnosis, treatment, prevention and control. 2nd edition. Geneva: World Health Organization; 1997.
2. Gubler DJ, Meltzer M. Impact of dengue/dengue haemorrhagic fever on the developing world. Adv Virus Res 1999;53:35-70.
3. Dengue prevention and control. Wkly Epidemiol Rec 2002;77:41-8.
4. Ferguson N, Anderson R, Gupta S. The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. Proc Natl Acad Sci U S A 1999;96:790-4.
5. Hay SI, Myers MF, Burke DS, Vaughn DW, Endy T, Ananda N, et al. Etiology of interepidemic periods of mosquito-borne disease. Proc Natl Acad Sci U S A 2000;97:9335-9.
6. Halstead SB. Observations related to the pathogenesis of dengue haemorrhagic fever. VI. Hypothesis and discussion. Yale J Biol Med 1970;42:350-62.
7. Thein S, Aung MM, Shwe TN, Aye M, Zaw A, Aye K, et al. Risk factors in dengue shock syndrome. Am J Trop Med Hyg 1997;56:566-72.
8. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000;181:2-9.
9. Nisalak A, Endy T, Nimmannitya S, Kalayanarooj S, Thisayakorn U, Scott RM, et al. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg 2003;68:191-202.
10. Communicable Disease Surveillance in Singapore. Singapore: Quarantine and Epidemiology Department, Ministry of the Environment; 2000.
11. Analysis of communicable disease data in Vietnam 1991-1995. Hanoi, Vietnam: Ministry of Health; 2000.
12. World Health Organization Collaborating Centre for Arbovirus Reference and Research (Dengue and dengue haemorrhagic fever). Annual reports. Kuala Lumpur: Department of Medical Microbiology, University of Malaya; 1990-2001.
13. Graham RR, Juffrie M, Tan R, Hayes CG, Laksono I, Ma'roef C, et al. A prospective seroepidemiological study on dengue in children in four to nine years of age in Yogyakarta, Indonesia 1. Studies in 1995-1996. Am J Trop Med Hyg 1999;61:412-9.
14. Kouri GP, Guzman MG, Bravo JR, Triana C. Dengue haemorrhagic fever/ dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bull World Health Organ 1989;67:375-80.
15. Hanna JN, Ritchie SA, Phillips DA, Serafin IL, Hills SL, van den Hurk A, et al. An epidemic of dengue 3 in far north Queensland, 1997-1999. Med J Aust 2001;174:178-82.
16. Wittke V, Robb TE, Thu HM, Nisalak A, Nimmannitya S, Kalayanrooj S, et al. Extinction and rapid emergence of strains of dengue 3 virus during an inter-epidemic period. Virology 2002;301:148-56.
17. Sittisombut N, Sistayanarain A, Cardosa MJ, Salminen M, Damrongdachakul S, Kalayanarooj S, et al. Possible occurrence of a genetic bottleneck in dengue serotype 2 viruses between the 1980 and 1987 epidemic seasons in Bangkok, Thailand. Am J Trop Med Hyg 1997;57:100-8.
18. Guzman MG, Kouri G, Halstead SB. Do escape mutants explain rapid increases in dengue case fatality rates within epidemics? Lancet 2000;355:1902-3.
19. Twiddy SS, Woelk CH, Holmes EH. Phylogenetic evidence for adaptive evolution of dengue viruses in nature. J Gen Virol 2002;83:1679-89.
20. Worobey M, Rambaut A, Holmes EH. Widespread intra-serotypic recombination in natural populations of dengue virus. Proc Natl Acad Sci U S A 1999;96:7352-7.
21. Clarke DH, Casals J. Techniques for haemagglutination and haemagglutination inhibition with arthropod-borne viruses. Am J Trop Med Hyg 1958;7:561-73.
22. Cuzzubbo AJ, Endy TP, Nisalak A, Kalayanarooj S, Vaughn DW, Ogata SA, et al. Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay. Clin Diagn Lab Immunol 2001;8:1150-5.
23. Henchal EA, Gentry MK, McCown JM, Brandt WE. Dengue virus specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am J Trop Med Hyg 1982;31:830-6.
24. Beasley DW, Aaskov JG. Epitopes on the dengue 1 virus envelope protein recognised by neutralising IgM antibodies. Virology 2001;279:447-58.
25. Lorenz IC, Allison SL, Heinz FX, Helenius A. Folding and dimerisation of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J Virol 2002;76:5480-91.